Open original FDA record ↗Recall record
- FDA identifier
- Z-1480-2011
- Company in FDA record
- Roche Insulin Delivery Systems Inc.
- FDA classification date
- Mar 10, 2011
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
There is the potential to kink or bend the cannula when inserting the ACCU-CHEK FlexLink Plus infusion set. This can lead to under delivery and elevation of blood glucose levels.
Source facts
- Action
- Roche Insulin Delivery Systems sent urgent Product Recall letters, dated 2/21/2011. The letter identified the affected product and described the issue regarding kinked or bent cannulas. The firm requests that customers discontinue use of the ACCU-CHEK FlexLink Plus infusion set and return the unused stock. Customers are to contact their health care provider to determine if changes to their pump therapy are needed and how to temporarily continue insulin pump therapy without the ACCU-CHEK FlexLink Plus infusion set. The attached Customer Reply Card should be completed and return via mail or fax per the instructions on the card. The letter also lists some additional information pertaining to signs and symptoms. Questions regarding this recall should be directed to ACCU-CHEK Customer Care at 1-800-688-4578, 24 hours a day, 7 days a week.
- Initiated
- 2011-02-24
- Root cause
- Device Design
- Terminated
- 2011-07-27
- Distribution
- Worldwide Distribution -- US and Canada.
- Recall number
- Z-1480-2011
- Recall status
- Terminated
- CDRH record ID
- 97975
- FDA classified
- 2011-03-10
- Recall event number
- 58015